Skip to main content
NIH funding notice PAR-18-023

Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)

Closed on January 7, 2020.

Posted
November 28, 2017
Close date
January 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,369,733 in first-year total cost, median $684,867.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 AARR-G (55)]2

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. UNIVERSITY OF PENNSYLVANIA1
Competing awards under PAR-18-023 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes1R01DA050482-01A1REDDY, KRISHNA PMASSACHUSETTS GENERAL HOSPITAL, MA$728,867ZRG1
2020Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana1R01DA045604-01A1GROSS, ROBERTSCHNOLL, ROBERT ADAMUNIVERSITY OF PENNSYLVANIA, PA$640,866ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-023: Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) | ScienceDex | ConductScience